Our data further confirmed SPRY4-IT1 regulated CRC cell growth and glycolysis via regulating PDK1 expression, and therefore thought SPRY4-IT1 as a potential molecular target for CRC treatment. Here, SPRY4 is linked to colorectal carcinoma.